News | April 27, 2022
Lupin and Yabao announce strategic partnership in China
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Tislelizumab is now approved for seven indications in China
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China
Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.
Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
This is the company’s first partnership arrangement in China
Subscribe To Our Newsletter & Stay Updated
